Treatment of chronic overmedicated headache patients

References

• Dreisbach RII. Experimental caffeine withdrawal headache. j Pharmacol Exp. Ther 69, 283 (1940).
   Google Scholar
• Wolfson WQ, Graham GR. Development of tolerance to ergot alkaloids in a patient with unusually severe migraine. N Engl. J. Med 241, 296–298 (1949).
   PubMedGoogle Scholar
• Peters GA, Horton BT Headache: with special reference to excessive use of ergotamine preparations and withdrawal effects. Mayo. Clin. Proc. 26, 214–226 (1951).
   Google Scholar
• Headache Classification Committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia 8\(Suppl. 7), 1–96 (1988). To understand the terminology and rationale that underlie this classification it is essential to understand the terms used and what they mean.
   Google Scholar
• Silberstein SD, Lipton RB, Solomon S, Mathew NT Classification of daily and near-daily headaches: proposed revisions to the IHS criteria. Headache 34, 1–7 (1994).
   PubMed Web of Science ®Google Scholar
• Silberstein SD, Lipton RB, Sliwinski M. Classification of daily and near-daily headaches: a field study of revised IHS criteria. Neurology47, 87–875 (1996).
   Google Scholar
• Pascual J, Colas R, Castillo J. Epidemiology of chronic daily headache. CL117: Pain. Headache Rep. 5(6), 529–36 (2001).
   Google Scholar
• Rasmussen BK, Jensen R, Schroll M, Olesen J. Epidemiology of headache in a general population: a prevalence study. J. Clin. Epidemiol 44, 1147–1157 (1991).
   PubMed Web of Science ®Google Scholar
• Dowson AJ. Migraine: assessment and management. Int. J. Gun. Pract. 55, 684–689 (2001).
   PubMedGoogle Scholar
• Scher Al, Stewart WF, Liberman J, Lipton RB. Prevalence of frequent headache in population sample. Headache 38, 497–506 (1998).
   PubMed Web of Science ®Google Scholar
• Castillo J, Munoz P, Guitera V, Pascual J. Epidemiology of chronic daily headache in the general population. Headache 39, 190–196 (1999).
   PubMed Web of Science ®Google Scholar
• Bekkelund SI, Salvesen R. Drug-associated headache is unrecognized in patients treated at a neurological center. Acta. Neural. Scantl 105 (2), 120–123 (2002).
   Google Scholar
• •Reports points of view/results that support clinical experiences in this field, and useful in practice for the treatment of patients, by using studied drugs.
   Google Scholar
• Manzoni GC, Granella F, Sandrini G, Cavallini A, Zanferrari C, Nappi G. Classification of chronic daily headache by International Headache Society criteria: limits and new proposals. Cephalalgla 15, 37–43 (1995).
   PubMed Web of Science ®Google Scholar
• Silberstein SD, Welch KMA. Painkiller headache. Neurology59, 972–974 (2002).
   PubMed Web of Science ®Google Scholar
• •Reports points of view/results that support clinical experiences in this field, and useful in practice for the treatment of patients, by using studied drugs.
   Google Scholar
• Sicuteri F, Nicolodi M. Visceral and somatic profiles of needless pain and nonpainful sensations in idiopathic headache. Clin. Pain 7\(Suppl. 1), 38–43 (1991).
   Google Scholar
• Mathew NT. Valproate in the treatment of persistent daily headache. An open label study. Headache 31, 71–74 (1991).
   Google Scholar
• Mathew NT. Transformed migraine. Cephalalgia 13\(Suppl. 1), 78–83 (1993).
   Google Scholar
• Limmroth V, Katsarava Z, Fritsche G, Przywara S, Diener HC. Features of medication overuse headache following overuse of different acute headache drugs. Neurology59, 1011–1014 (2002).
   Google Scholar
• •Reports points of view/results that support clinical experiences in this field, and useful in practice for the treatment of patients, by using studied drugs.
   Google Scholar
• Lance JW, Curran DA. Treatment of chronic tension headache. Lancet 1, 1236–1239 (1964).
   PubMed Web of Science ®Google Scholar
• Tepper SJ. Analgesic overuse is a cause of Chronic Daily Headache. Headache 42, 543–546 (2002). Debates the possible relationship between analgesic drugs used to treat headache and the chronicization of headache itself. This point is crucial because if headache is a consequence of analgesics, it is mandatory to stop the drug intake. On the other hand, if there is not a direct causal relationship, the use of these drugs could be modulated and the first phase of treatment could be more prolonged.
   Google Scholar
• Gobel H, Stolze H, Heinze A, Dworschak M. Easy therapeutical management of sumatriptan-induced daily headache. Neurology47, 297–298 (1996).
   PubMedGoogle Scholar
• Wilkinson SM, Becker WJ, Heine JA. Opiate use to control bowel motility may induce chronic daily headache in patients with migraine. Headache 41, 303–309 (2001).
   Google Scholar
• Rapoport AM. Analgesic rebound headache. Headache 28, 662–665 (1988).
   PubMed Web of Science ®Google Scholar
• Zed PJ, Loewen PS, Robinson G. Medication-induced headache: overview and systematic review of therapeutic approaches. Ann. Pharmacother 33, 61–72 (1999).
   Google Scholar
• Dodick DW. Analgesic overuse is not a cause of chronic daily headache. Headache 42, 546–554 (2002). Debates the possible relationship between analgesic drugs used to treat headache and the chronicalization of headache itself. This point is crucial because if headache is a consequence of analgesics, it is mandatory to stop the drug intake. On the other hand, if there is not a direct causal relationship, the use of these drugs could be modulated and the first phase of treatment could be more prolonged.
   Google Scholar
• Silverman K, Evans SM, Strain EC, Griffiths RR. Withdrawal syndrome after the double-blind cessation of caffeine consumption. N. Engl. Med. 327, 1109–1114 (1992).
   PubMed Web of Science ®Google Scholar
• Ad Hoc Committee. Do caffeine- containing analgesic promote dependance? A review and evaluation. Gun. Pharmacol Ther 68, 457–467 (2000).
   PubMedGoogle Scholar
• •Reports points of view/results that support clinical experiences in this field, and useful in practice for the treatment of patients, by using studied drugs.
   Google Scholar
• Vanderah TW, Suenaga NM, Ossipov MH, Malan TP Jr., Lai J, Porreca F. Tonic descending facilitation from the rostral ventromedial medulla mediates opioid-induced abnormal pain and antinociceptive tolerance. J. Neurosci. 21, 279–286 (2001).
   Google Scholar
• Vanderah TVV, Gardell LR, Burgess SE et al Dynorphin promotes abnormal pain and spinal opioid antinociceptive tolerance. Neurosci. 20, 7074–7079 (2000).
   Web of Science ®Google Scholar
• Sandrini M, Vitale G, Ottani A, Pini LA. The potentiation of analgesic activity of paracetamol plus morphine involves the serotonergic system in rat brain. Intlamm. Res. 48, 120–127 (1999).
   Google Scholar
• Srikiatkhachorn A, Tarasub N, Govitrapong P. Effect of chronic analgesic exposure on the central serotonin system, a possible mechanism of analgesic abuse headache. Headache 40, 343–350 (2000).
   Google Scholar
• Srikiatkhachorn A. Chronic daily headache: a scientist's perspective. Headache 42, 532–537 (2002). Reviews the scientific knowledge about this problem. The pathogenetic mechanism underling the chronicization of pain could represent the future tool for treatment of these types of patients.
   Google Scholar
• Katsarava Z, Fritsche G, Muessig M, Diener HC, Limmroth V. Clinical features of withdrawal headache following overuse of triptans and other headache drugs. Neurology57, 1694–1698 (2001).
   Google Scholar
• Silberstein SD, Lipton RB, Goadsby PJ. Headache in clinical practice. In: Medical Media. Oxford, UK 101–114 (1998).
   Google Scholar
• Hering R, Steiner TJ. Abrupt outpatient withdrawal of medication in analgesic-abusing migraineurs. Lancet337, 1442–1443 (1991).
   PubMed Web of Science ®Google Scholar
• Diener, HC, Pfaffenrath V, Soylka D, Gerber WD. Therapie des Medikamenten induzierten Dauerkopfschmerzen. Munich Med. Wschr 134, 159–162 (1992).
   Google Scholar
• Cano A, Roquer J. Tratamiento ambulatorio de la cefalea cronica secundaria al abuso de preparados ergoticos. Aten. Primatia. 17, 179–81 (1996).
   PubMedGoogle Scholar
• Krymchantowski AV, Barbosa JS. Prednisone as initial treatment of analgesic-induced daily headache. Cephalalgia 20, 107–113 (2000).
   PubMed Web of Science ®Google Scholar
• Saper JR, Lake AE, Cantrell DT, Winner PK, White JR. Chronic daily headache prophylaxis with Tizanidine: a double-blind, placebo-controlled, multicenter outcome study. Headache 42, 470 (2002).
   PubMed Web of Science ®Google Scholar
• Krymchantowski AV, Silva,MT, Barbosa JS, Alves LA. Amitriptyline versusamitriptyline combined with fluoxetine in the preventative treatment of transformed migraine: a double-blind study. Headache 42, 510–514 (2002).
   PubMed Web of Science ®Google Scholar
• Descombes S, Brefel-Courbon C, Thalamas C etal Amitriptyline treatment in chronic drug-induced headache: a double-blind comparative pilot study. Headache 41, 178–182 (2001).
   PubMed Web of Science ®Google Scholar
• Bonuccelli U, Nuti A, Lucetti C, Pavese N, Dell Agnello G, Muratorio A. Amitriptyline and dexamethasone combined treatment in drug-induced headache. Cephalalgia 16, 198-200 (1996).
   PubMedGoogle Scholar
• Tomkins GE, Jackson JL, O'Malley PG, Balden E, Santoro JE. Treatment of chronic headache with antidepressants: a meta-analysis. Am. Med 111, 54–63 (2001).
   Google Scholar
• •Reports points of view/results that support clinical experiences in this field, and useful in practice for the treatment of patients, by using studied drugs.
   Google Scholar
• Pini LA, Bigarelli M, Vitale G, Sternieri E. Headaches associted with chronic use of analgesics. A therapeutic approach. Headache 36, 433–439 (1996).
   Google Scholar
• Schwartz TH, Karpitskiy VV, Sohn RS. Intravenous valproate sodium in the treatment of daily headache. Headache 42, 519 (2002)
   PubMed Web of Science ®Google Scholar
• Silberstein SD, Liu D. Drug overuse and rebound headache. CU17: Pain Headache Rep. 6, 240–247 (2002).
   Google Scholar
• •Reports points of view/results that support clinical experiences in this field, and useful in practice for the treatment of patients, by using studied drugs.
   Google Scholar
• Pini LA, Cicero AFG, Sandrini M. Long-term follow-up of patients treated for chronic headache with analgesic overuse. Cephalalgia 21, 878–883 (2001).
   Google Scholar
• •Reports points of view/results that support clinical experiences in this field, and useful in practice for the treatment of patients, by using studied drugs.
   Google Scholar
• Diener HC, Dichgans J, Scholz F, Geiselhart S, Gerber WD, Bille A. Analgesic-induced chronic headache: long-term results of withdrawal therapy. Neural 236, 9–14 (1989).
   PubMed Web of Science ®Google Scholar
• Suhr B, Evers S, Bauer B, Gralow I, Grotemeyer KH, Husstedt IW. Drug-induced headache: long-term results of stationary versus ambulatory withdrawal therapy. Cephalalgia 19, 44–49 (1999).
   PubMed Web of Science ®Google Scholar
• Lu SR, Fuh JL, Chen WT, Juang KD, Wang SJ. Chronic daily headache in Taipei, Taiwan: prevalence, follow-up and outcome predictors. Cephalalgia 21, 980–986 (2001).
   PubMed Web of Science ®Google Scholar
• Tfelt-Hansen P, Aebelholt Krabbe A. Ergotamine abuse. Do patients benefit from withdrawal? Cephalalgia 1, 29–32 (1981).
   Google Scholar
• Schnider P, Aull S, Baumgartner CH, Tribl GC, Wöber C. Long-term outcome of patients with headache and drug abuse after in-patients withdrawal: five years follow-up. Cephalalgia 16, 481–485 (1996).
   PubMed Web of Science ®Google Scholar
• Baumgartner CH, Wessely P, Bingöl C, Maly J, Holzner E Long-term prognosis of analgesic withdrawal in patients with drug-induced headaches. Headache 29, 510–514 (1989).
   PubMed Web of Science ®Google Scholar
• Tribl GC, Schnider P, Woeber C etal Are there predictive factors for long-term outcome after withdrawal in drug-induced chronic daily headache? Cephalalgia 21, 691–696 (2001). Reports points of view/results that support clinical experiences in this field, and useful in practice for the treatment of patients, by using studied drugs.
   Google Scholar
• Silbersein SD, McCrory DC. Butalbital in the treatment of headache: history, pharmacology and efficacy. Headache 41, 953–957 (2001).
   PubMedGoogle Scholar
• Walker J, Parisi S, Olive D. Analgesic rebound headache experience in a community hospital. South Merl 1. 86, 1202–1205 (1993).
   Google Scholar
• Bigal EM, Rapaport Am, Sheftell DF, Tepper SJ. Long-term follow-up of patients treated for chronic daily headache with analgesic overuse. Cephalalgia 22, 432–436 (2002).
   PubMed Web of Science ®Google Scholar
• •Reports points of view/results that support clinical experiences in this field, and useful in practice for the treatment of patients, by using studied drugs.
   Google Scholar
• Katsarava Z, Diener HC, Limmroth V. Medication overuse headache: a focus on analgesics, ergot alkaloids and triptans. Drug- Sal 24, 921–927 (2001).
   PubMedGoogle Scholar
• •Reports points of view/results that support clinical experiences in this field, and useful in practice for the treatment of patients, by using studied drugs.
   Google Scholar
• Grazzi L, Andrasik F, D'Amico D et al Behavioral and pharmacologic treatment of transformed migraine with analgesic overuse: outcome at 3 years. Headache 42, 483 (2002).
   PubMed Web of Science ®Google Scholar
• Puca F, Genco S, Prudenzano MP et al Psychiatric comorbidity and psychosocial stress in patients with tension-type headache from headache centers in Italy. Cephalalga 19, 159–64 (1999).
   PubMed Web of Science ®Google Scholar